News
-
-
COMMUNIQUÉ DE PRESSE
Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Worksport Ltd. reports a 90% YoY revenue increase in fiscal year 2025, with significant margin expansion and commercialization milestones achieved. The company provides financial guidance for 2026 and highlights achievements in dealer network growth and product launches -
-
COMMUNIQUÉ DE PRESSE
Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer. Company's buyback program exceeded maximum shares tendered. Offer price to be available by 2 April 2026 -
COMMUNIQUÉ DE PRESSE
Informations privilégiées / Communiqué sur comptes, résultats
Advicenne annonce ses résultats financiers 2025: chiffre d'affaires en hausse, ventes européennes de Sibnayal® en progression, doublement des royalties et horizon de financement à mi T2 2026. Approbation des comptes par le Conseil d'administration -
COMMUNIQUÉ DE PRESSE
Inside Information / News release on accounts, results
Advicenne reports its 2025 annual financial results, including a 18.7% increase in product sales, Sibnayal®'s growth in Europe, and the expected US Marketing Authorization. The company aims to extend its cash runway and restructure its balance sheet -
-
COMMUNIQUÉ DE PRESSE
Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Critical Path Institute launches 'One to Millions' global initiative to accelerate individualized medicine access worldwide by leveraging advanced therapeutic treatments and regulatory frameworks -
-
COMMUNIQUÉ DE PRESSE
2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
2CRSi annonce des résultats solides pour le 1er semestre 2025/26 avec un CA de 204,7 M€ (x9,8) et un EBITDA de 9,6 M€ (x4,6), grâce à la demande croissante pour ses serveurs haute performance
